08 September 2021 | NewsCOVID-19 Delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021Read the full article
The first Australian COVID-19 active vaccine safety surveillance data are now available from AusVaxSafety.
AusVaxSafety active vaccine safety surveillance uses a short survey sent by SMS/email to collect reports of adverse events following immunisation directly from the people receiving COVID-19 vaccines.
An adverse event following immunisation (AEFI) is any untoward event which follows immunisation and which does not necessarily have a causal relationship with the use of the vaccine.
In summary from surveys received up to 28 February 2021 in the first week of vaccination in Australia:
The most commonly reported symptoms were pain at the injection site, fatigue and headache. These symptoms are known to occur after vaccination. They are generally mild and short-lived. As with any adverse event reports, not all symptoms reported may be caused by the vaccine; they may be coincidental and due to other causes.
These results are consistent with those seen in clinical trials and with other vaccines, reaffirming the safety of the current vaccine in use in Australia.
View the AusVaxSafety COVID-19 vaccination surveillance data here
The safety data will be updated weekly.
Read more about how AusVaxSafety is conducting national COVID-19 vaccine safety surveillance in Australia here.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS